Clients News • MC Services corporate website
paged,page-template-default,page,page-id-5522,paged-3,page-paged-3,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.4.2,vc_responsive




  • Relief and NeuroRx Conclude Enrollment in their Phase 2b/3 Trial of RLF-100™ for Critical COVID-19 with Respiratory Failure
  • Abivax’s Covid-19 Phase 2b/3 miR-AGE trial with ABX464 declared Research National Priority by the French government’s Clinical Trial Council
  • Apogenix AG – COVID-19: targeted treatment trial launched in Vienna
  • Adocia announces its financial calendar for 2021
  • Abivax to present at the 39th Annual J.P. Morgan Healthcare Conference ahead of major clinical milestones
  • Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China
  • Relief Appoints Chris L.J.J. Stijnen as Chief Commercial Officer
  • Relief Announces Results of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding AG Approved with Large Majority
  • XPHYTO Therapeutics completes successful SARS-CoV-2 RT-PCR diagnostic test kit validation
  • 4basebio AG – Update regarding the status of the settlement of the spin-off